Skip to content
10-Q

Quarterly Report

BIOVERATIV INC.

0001558370-17-004227

← back to feed
Filed
May 12, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 1, 2017 108.16M sh
Shares Diluted Q1 2017 · Mar 31, 2017 108.2M sh
Shares Diluted Q1 2017 · Mar 31, 2016 108M sh
Capex Q1 2017 · Mar 31, 2017 $6.3M
Capex Q1 2017 · Mar 31, 2016 $900K
Cash And Equivalents Q1 2017 · Mar 31, 2017 $358.7M
Stockholders Equity Q1 2017 · Mar 31, 2017 $585.1M
Stockholders Equity Q1 2017 · Dec 31, 2016 $566.2M
Stockholders Equity Q1 2017 · Mar 31, 2016 $404.8M
Stockholders Equity Q1 2017 · Dec 31, 2015 $384.7M
Current Liabilities Q1 2017 · Mar 31, 2017 $138.4M
Current Liabilities Q1 2017 · Dec 31, 2016 $102M
Total Liabilities Q1 2017 · Mar 31, 2017 $211.5M
Total Liabilities Q1 2017 · Dec 31, 2016 $165.7M
Current Assets Q1 2017 · Mar 31, 2017 $678.7M
Current Assets Q1 2017 · Dec 31, 2016 $475.6M
Total Assets Q1 2017 · Mar 31, 2017 $796.6M
Total Assets Q1 2017 · Dec 31, 2016 $731.9M
Sga Expense Q1 2017 · Mar 31, 2017 $47M
Sga Expense Q1 2017 · Mar 31, 2016 $39M
Rd Expense Q1 2017 · Mar 31, 2017 $36.9M
Rd Expense Q1 2017 · Mar 31, 2016 $54.3M
Operating Income Q1 2017 · Mar 31, 2017 $111.9M
Operating Income Q1 2017 · Mar 31, 2016 $65.9M
Cost Of Revenue Q1 2017 · Mar 31, 2017 $63.3M
Cost Of Revenue Q1 2017 · Mar 31, 2016 $32.5M
Revenue Q1 2017 · Mar 31, 2017 $259.1M
Revenue Q1 2017 · Mar 31, 2016 $191.7M